Moreover, patients who are not at target (A1C < 7%) with high doses of basal insulin (> 0.5 U/kg) or those who are at increased risk of nocturnal hypoglycemia need further insulin intensification [7]. This evidence concerns the gene INS and Hypoglycemia.